<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
83468-070-03
</NDCCode>
<PackageDescription>
2 CONTAINER in 1 CARTON (83468-070-03) / 2 VIAL, SINGLE-DOSE in 1 CONTAINER (83468-070-02) / .2 mL in 1 VIAL, SINGLE-DOSE (83468-070-01)
</PackageDescription>
<NDC11Code>
83468-0070-03
</NDC11Code>
<ProductNDC>
83468-070
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Cardamyst
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Etripamil
</NonProprietaryName>
<DosageFormName>
SPRAY
</DosageFormName>
<RouteName>
NASAL
</RouteName>
<StartMarketingDate>
20260105
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
NDA218571
</ApplicationNumber>
<LabelerName>
Milestone Pharmaceuticals USA, Inc.
</LabelerName>
<SubstanceName>
ETRIPAMIL
</SubstanceName>
<StrengthNumber>
70
</StrengthNumber>
<StrengthUnit>
mg/.2mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-01-05
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20260105
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>